Regenerex Pharma (RGPX) Interest Coverage Ratio (2013 - 2025)

Regenerex Pharma (RGPX) reported Interest Coverage Ratio of 196.68 for Q3 2025, down 20159.39% year-over-year from N/an in Q3 2024, and down 632.24% quarter-over-quarter from 26.86 in Q2 2025.

Regenerex Pharma (RGPX) Interest Coverage Ratio (2013 - 2025) Analysis & Trends

Regenerex Pharma (RGPX) has 9 years of Interest Coverage Ratio data on file, last reported at 196.68 in Q3 2025.

  • Interest Coverage Ratio for Q3 2025 came in at 196.68, down 20159.39% year-over-year; the trailing twelve-month figure through Sep 2025 was 7.63 (down 185.95% YoY), and the FY2025 annual result was 5.71, up 86.72% from the prior year.
  • Interest Coverage Ratio fell to 196.68 in Q3 2025 per RGPX's latest filing, from 26.86 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 0.43 in Q1 2023 and troughed at 196.68 in Q3 2025.
  • A 5-year average of 23.81 and a median of 3.44 in 2024 frame the typical range for Interest Coverage Ratio.
  • The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio soared 99.31% in 2024, then tumbled 20159.39% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 4.26 in 2021, then jumped by 60.38% to 1.69 in 2022, then plunged by 601.42% to 11.84 in 2023, then increased by 2.61% to 11.53 in 2024, then sank by 1605.7% to 196.68 in 2025.
  • Business Quant data shows RGPX's Interest Coverage Ratio at 196.68 in Q3 2025, 26.86 in Q2 2025, and 3.3 in Q1 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 -196.68
Jun 30, 2025 -26.86
Mar 31, 2025 -3.30
Dec 31, 2024 -11.53
Sep 30, 2024 -0.97
Jun 30, 2024 -11.39
Mar 31, 2024 -3.59
Dec 31, 2023 -11.84
Sep 30, 2023 -140.70
Jun 30, 2023 -8.66
Mar 31, 2023 -0.43
Dec 31, 2022 -1.69
Sep 30, 2022 -1.29
Jun 30, 2022 -1.11
Mar 31, 2022 -2.11
Dec 31, 2021 -4.26
Sep 30, 2021 -1.25
Jun 30, 2021 -0.92
Dec 31, 2020 -1.27
Sep 30, 2020 -1.11